FDA Delays Final OK for Type 2 Drug Empagliflozin
The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at
Read MoreThe FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at
Read MoreThe name alone is a mouthful. Sodium-glucose cotransporter-2 inhibitors are one of the newest class of drugs meant to treat
Read MoreA Massachusetts-based research firm concludes that the first-world market for type 2 drugs and treatments will increase from $27 billion
Read MoreIf you Google “type 2 diabetes drugs,” one website lists the names of 92 drugs that medical professionals have prescribed
Read MoreA new, first-in-its-class drug for type 2 diabetes has just been approved by the Food and Drug Administration. Invokana works
Read More